Stocktoria

Sionna Therapeutics, Inc. SION

Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2025-02-07

Sionna Therapeutics, Inc. statistics & valuation

P / B6.2×

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.

Key ratios (by fiscal year)

RatioFY2025FY2024
Return on assets-23.1%-33.2%
Return on equity-24.5%37.7%
Current ratio20.6114.49

Source: SEC EDGAR filings · CIK 0002036042 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.